Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
about
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying HypothesisMultiple Sclerosis: Where Will We Be in 2020?Environmental risk factors for multiple sclerosis. Part II: Noninfectious factorsEpstein-Barr virus infection is not a characteristic feature of multiple sclerosis brainEBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationSystematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosisThe role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differencesEnvironmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsAnti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosisEpidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel WorkshopEpstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosisEpstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapyEpstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patientsThe causal cascade to multiple sclerosis: a model for MS pathogenesis.Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literatureRegulatory lymphocytes are key factors in MHC-independent resistance to EAEElevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosisAntiviral immune responses: triggers of or triggered by autoimmunity?Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosisEnvironmental risk factors in multiple sclerosis.Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studiesAnti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity.Potential triggers of MSVitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.Tracing environmental markers of autoimmunity: introducing the infectome.Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosisEpstein-Barr virus and rheumatoid arthritis: is there a link?Primary infection with the Epstein-Barr virus and risk of multiple sclerosisEpstein-barr virus, the immune system, and associated diseasesVitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.Role of pathogens in multiple sclerosisAnti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.The initiation and prevention of multiple sclerosis.Epstein-barr virus: environmental trigger of multiple sclerosis?XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, Iran
P2860
Q21296711-8F37FB4E-31D6-46D2-8DE7-C5235F1D6A78Q22252863-CFA3ECB6-36DB-4E86-8822-1943F501EA73Q22252931-A34F5E1D-3A2D-4278-A68B-867953FA92BEQ24642187-E241ABC0-2612-4745-A6BE-0FB51A41A828Q24657388-19FA88A1-FCBD-46E4-B00D-D58D6581C3FBQ26830464-3A73550D-CDFA-4189-8A67-F1C0FDDAD138Q26852295-5E6E303D-FC79-4A51-9083-85745E76E1D5Q26866256-1F468AD9-2EB3-461F-B9AE-BF30DBD33B42Q27006548-7033A7A8-9AC1-4D9D-AB56-E021A96B136BQ28245682-28C7D256-0289-4438-8542-95E4669886C9Q28390922-7FC652BD-8154-4340-958B-A07091CCC76EQ28731829-86B87B2A-27C0-42F4-B92A-AE02E2FF2232Q30878158-6EBAD5B4-C2EA-4898-B8D5-C5FB5F99B78EQ31104121-39944E61-3B49-46E8-B04F-BADAA57F9267Q33412374-C2DBA851-9312-4BDF-A1C4-D1C14878C522Q33592080-22E8B84E-A415-4384-8F03-A20A1EFCEE4BQ33608305-67E43379-3877-47EB-8E15-82E4B504D21FQ33764503-971E88B3-C4B9-4D20-A27C-0FBE25093849Q33789445-99936418-5C0D-4E44-A0C8-84012A4F9329Q34076940-F75B0DE0-3D29-4DF2-8C30-5EDC6A580BE4Q34100847-D6A16561-653C-4E6F-878A-1ADE7BEA58CFQ34280356-0A4B97CD-CA72-482D-B96D-71E116377E90Q34343202-5282E4D9-7CF4-4907-A864-B0CC516EEB78Q34537607-311F39F8-79F4-4CBB-9EBA-20D4FEF4DB80Q34624709-BB4BB869-8DA8-4D73-B96D-7D13FF790A3BQ34641782-FE8EFA7D-89BD-4832-9343-465B8CA926A6Q34671373-7E0658AB-9627-4341-829F-FDC3DBBB2DBBQ34671815-6D32BF91-068A-4281-9048-C53C45385DDCQ34896078-15F0D606-BB46-4B57-A05C-10371DC4C3B9Q34952674-299E712C-966B-4A84-8AFC-EF45A4411C25Q35029255-54FBFF2B-7CC8-4587-B5E4-FE7611000831Q35098876-351A0BFB-AD53-464E-8C70-0688C3C496A8Q35130524-EDBB64BD-D4EC-4490-8924-D1FEBE9E9E86Q35206805-BE41711F-3139-4DE2-B91D-2B339E32600DQ35231431-8338B267-0491-414E-B584-FBDE7EE36859Q35674246-687CDF75-3D2B-49B0-940F-473D40E20362Q35741861-F2C1483D-0D1D-49E6-AD37-7DAA58008069Q35914342-3A147D75-4168-4A9F-B70B-DC25EEE586BEQ35956144-3413010F-F618-40FC-994F-82D1BB26201EQ35993313-CE81A9B3-7C42-406C-BE82-2C0BA5D20A62
P2860
Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Temporal relationship between ...... ymptoms in multiple sclerosis.
@ast
Temporal relationship between ...... ymptoms in multiple sclerosis.
@en
Temporal relationship between ...... ymptoms in multiple sclerosis.
@nl
type
label
Temporal relationship between ...... ymptoms in multiple sclerosis.
@ast
Temporal relationship between ...... ymptoms in multiple sclerosis.
@en
Temporal relationship between ...... ymptoms in multiple sclerosis.
@nl
prefLabel
Temporal relationship between ...... ymptoms in multiple sclerosis.
@ast
Temporal relationship between ...... ymptoms in multiple sclerosis.
@en
Temporal relationship between ...... ymptoms in multiple sclerosis.
@nl
P2093
P921
P356
P1476
Temporal relationship between ...... ymptoms in multiple sclerosis.
@en
P2093
Charles A Peck
Evelyne T Lennette
Kassandra L Munger
Lynn I Levin
Mark V Rubertone
P304
P356
10.1001/JAMA.293.20.2496
P407
P577
2005-05-01T00:00:00Z